Biopharma pipelines depend on securely aggregating clinical, manufacturing, and commercial data.
We engineer the data integration and AI architecture for drug development and commercialization. The systems connect disparate silos to accelerate trials and optimize market access.
Data drives the pipeline.
Trial design, site selection, and commercial targeting rely on massive, fragmented datasets. AI provides the leverage to match patients to trials and predict supply chain disruptions, but only if the underlying data is integrated.
Security and integration first.
We prioritize patient privacy and data lineage. We implement architectures that allow secure computation over sensitive health data, ensuring compliance with HIPAA and GDPR while extracting operational insights.
Clinical operations and commercialization.
We deploy AI to optimize trial operations, from protocol design to site monitoring. On the commercial side, we engineer the systems that synthesize real-world evidence to support pricing and market access.
Three ways Talbot West works inside Biopharma.
Modernization strategy
Decide where to invest, what to prioritize, what should happen first, and what evidence should change the plan.
Explore service ↗02Data engineering
Make data quality, ownership, lineage, and availability explicit before decisions or operating systems depend on them.
Explore service ↗03AI engineering
Use AI where it earns its place, from commodity capabilities and orchestration to proprietary engineering where organization-specific value justifies it.
Explore service ↗Put this sector view to work
Find out where you stand and what you can do about it.